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The protein encoded by MAP1272c has been shown to be an antigen of Mycobacterium avium subsp. paratuberculosis that con-
tains an NlpC/P60 superfamily domain found in lipoproteins or integral membrane proteins. Proteins containing this domain
have diverse enzymatic functions that include peptidases, amidases, and acetyltransferases. The NlpC protein was examined in
comparison to over 100 recombinant proteins and showed the strongest antigenicity when analyzed with sera from cattle with
Johne’s disease. To further localize the immunogenicity of NlpC, recombinant proteins representing defined regions were ex-
pressed and evaluated with sera from cattle with Johne’s disease. The region from amino acids 74 to 279 was shown to be the
most immunogenic. This fragment was also evaluated against a commercially available enzyme-linked immunosorbent assay
(ELISA). Two monoclonal antibodies were produced in mice immunized with the full-length protein, and each recognized a dis-
tinct epitope. These antibodies cross-reacted with proteins from other mycobacterial species and demonstrated variable sizes of
the proteins expressed from these subspecies. Both antibodies were further analyzed, and their interaction with MAP1272c and
MAP1204 was characterized by a solution-based, luminescent binding assay. These tools provide additional means to study a
strong antigen of M. avium subsp. paratuberculosis.
The search for strong yet specific Mycobacterium avium subsp.paratuberculosis antigens has been a recent focus in many lab-
oratories throughout the world (2, 17, 20, 23). This is because the
bacterium is a significant veterinary pathogen of cattle, goats, and
other ruminant animals. More specifically, M. avium subsp. para-
tuberculosis causes Johne’s disease (JD), a chronic enteritis that
results in weight loss due to poor absorption of nutrients through
strikingly inflamed ileum and jejunum tissues (11). The dairy in-
dustry incurs substantial economic losses due to reduced milk
production, premature culling, and reduced slaughter value (27).
The bacterium is shed in the feces and milk of animals in the
clinical phase of disease. Transmission is by ingestion of the bac-
terium while grazing on pastures contaminated by this shedding
process. Milk, passed from the infected dam to the daughter, has
also been shown as a transmission route (30).
Further driving the search for antigens is the nature of the
protein preparations currently used in diagnostic tests for JD, such
as the enzyme-linked immunosorbent assay (ELISA). Several
types of M. avium subsp. paratuberculosis antigen preparations
have been evaluated and used for serodiagnosis of JD for over 2
decades (25). These crude mycobacterial extracts or fractionated
preparations naturally contain multiple proteins, lipids, and car-
bohydrates, most of which are highly conserved across the Myco-
bacterium avium complex (MAC). The primary focus of current
research is on improving the sensitivity of the ELISA without ad-
versely affecting the specificity. The problem of specificity has
largely been overcome by incorporating an absorption step with
an extract from Mycobacterium phlei into most ELISA protocols to
remove cross-reacting antibodies (24, 38, 39). The protoplasmic
antigen preparation (PPA) and lipoarabinomannan (LAM) have
been adapted to commercial ELISAs (31, 38). To date, no M.
avium subsp. paratuberculosis recombinant proteins have been in-
corporated into a commercially available ELISA for JD.
MAP1272c encodes a protein containing an NlpC/P60 super-
family domain. Similar to Corynebacterium glutamicum (34),
there are five distinct NlpC/P60 domain-containing proteins en-
coded by the M. avium subsp. paratuberculosis K-10 genome se-
quence, including MAP0036, MAP1203, MAP1204, MAP1272c,
and MAP1928c. For the purposes of this study, we have termed the
MAP1272c-encoded protein NlpC. Proteins containing these do-
mains have diverse enzymatic functions, including hydrolyases
with specificity for amide linkages in peptidoglycan (1). A P60
domain-containing protein capable of peptidoglycan hydrolysis
in Listeria monocytogenes was shown to be secreted via the SecA2-
dependent mechanism (18). Mutations in secA2 reduced the vir-
ulence of L. monocytogenes and Mycobacterium tuberculosis (8, 19,
32). M. avium subsp. paratuberculosis also has SecA2 encoded by
MAP1534 (21), and deletion of this gene results in attenuation in
mouse macrophages (9, 21).
We have shown previously that NlpC is antigenic; however, the
thrust of that study was to apply a high-throughput recombinant
protein production method (22). Therefore, its immunogenicity
was not evaluated relative to that of other M. avium subsp. para-
tuberculosis proteins. The studies presented here evaluate the an-
tigenicity of this protein in greater detail by comparing it to other
recombinant proteins as well as a commercial ELISA. In addition,
we developed monoclonal antibodies (MAbs) to this important
M. avium subsp. paratuberculosis antigen for use in downstream
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applications and characterized their interactions with and speci-
ficities for NlpC in biochemical detail.
MATERIALS AND METHODS
Bacterial strains and culture. M. avium subsp. paratuberculosis strain
K-10 was cultured in Middlebrook (MB) 7H9 broth supplemented with
oleic acid, albumin, dextrose, and catalase (OADC) enrichment and my-
cobactin J (2 mg/liter) for 3 weeks at 37°C. Mycobacterium avium complex
strains and other mycobacterial strains listed in Table S1 in the supple-
mental material were maintained in Middlebrook 7H9 broth supple-
mented with OADC enrichment for 4 days at 37°C. All cultures were free
of contaminating organisms as assessed by absence of growth on brain
heart infusion agar (BD Microbiology).
Cloning and protein production. The whole-cell sonicated extracts
from mycobacterial species and isolates were prepared as previously de-
scribed (35). These preparations were used as the source of antigen for this
study. The full-length NlpC and all proteins spotted on the nitrocellulose
array were expressed as maltose binding protein (MBP) fusion proteins
and purified as described previously (5).
Both full-length and truncated versions of MAP1272c were also sub-
cloned into the Escherichia coli overexpression vector pT7HMT (14). The
primers for these truncated and full-length constructs are listed in Table
S2 in the supplemental material. The sequence-confirmed plasmids were
transformed into E. coli strain BL21(DE3) for overexpression and purifi-
cation, which were carried out according to the general protocols outlined
in reference 14. Upon completing the initial rounds of affinity purifica-
tion, the polyhistidine fusion tag was proteolytically removed by adding
recombinant tobacco etch virus (TEV) protease as described previously
(14). The samples were then desalted into 20 mM sodium formate buffer
(pH 3.5), and final purification was achieved with Resource S cation ex-
change chromatography using a GE Biosciences Akta fast protein liquid
chromatography (FPLC) system.
NlpC truncation A (NlpC-A) was also overexpressed from a modified
version of the pT7HMT vector that encodes a cysteine residue as the first
amino acid of the polypeptide of interest (13). Site-specifically biotinyl-
ated Cys-NlpC-A was produced using the EZ-Link maleimide-PEG2-bi-
otin reagent (Thermo Fisher Scientific [Rockford, IL]) according to the
manufacturer’s suggestions. Successful biotinylation at this site alone (as
NlpC lacks naturally occurring cysteine residues in its sequence) was con-
firmed by Western blotting using a streptavidin-conjugated anti-horse-
radish peroxidase (anti-HRP) antibody and SuperSignal Pico chemilumi-
nescent substrate (Thermo Fisher Scientific [Rockford, IL]).
Bovine serum samples. A set of well-characterized serum samples
from Prionics AG (Schlieren-Zurich, Switzerland) and the National Vet-
erinary Services Laboratory (Ames, IA) was used to evaluate recombinant
antigens by ELISA and immunoblotting. Characteristics of these serum
samples are listed in Table S3 in the supplemental material.
Production of monoclonal antibodies. Monoclonal antibodies were
produced using standard methods (15). Briefly, BALB/c mice were immu-
nized three times intraperitoneally with the MAP1272c recombinant pro-
tein (100 g per injection) suspended in 0.5 ml of phosphate-buffered
saline (PBS) (pH 7.3) at 14-day intervals. The antigen was emulsified in
Freund’s incomplete adjuvant for all immunizations. Humoral immune
responses of each mouse were evaluated by preparative immunoblot anal-
ysis using the sonicated M. avium subsp. paratuberculosis whole-cell anti-
gen. Cell fusions with splenic lymphocytes and myeloma cells were per-
formed on the best responder mouse. Positive antibody-secreting
hybridomas were identified by immunoblot screening with culture super-
natant. Stable secreting hybridomas were immunotyped using the isotype
kit I from Thermo Fisher Scientific (Rockford, IL).
Purification of monoclonal antibodies 8G6 and 14C5. Mouse hy-
bridoma cells were grown in RPMI medium supplemented with 10% fetal
bovine serum and 2 mM L-glutamine. Cells were incubated at 37°C in the
presence of 5% (vol/vol) CO2. Cells were passaged upon reaching 90%
confluence, which typically required 3 days of incubation time. In this
manner, approximately 1 liter of conditioned culture medium was col-
lected for each cell line and clarified by high-speed centrifugation. The
samples of clarified culture medium were concentrated 10-fold and buffer
exchanged by tangential-flow filtration into 20 mM borate (pH 8.3), 3.0 M
NaCl, and injected onto a 5-ml HiTrap protein G-Sepharose column (GE
Biosciences). Following extensive washing to remove nonspecifically
bound contaminants, bound IgG was eluted from the column using a
buffer of 0.1 M glycine (pH 2.0) and the eluate was immediately neutral-
ized by adding 1/10 volume of 1 M Tris (pH 8.0). The purified IgG was
concentrated and buffer exchanged into PBS for storage at 4°C until
needed.
Immunoblot assay. Protein separation was conducted by electropho-
resis using 12% (wt/vol) polyacrylamide gels. Electrophoretic transfer of
proteins onto pure nitrocellulose was accomplished with the Bio-Rad
Trans-Blot cell (Bio-Rad Laboratories, Richmond, CA) with sodium
phosphate buffer (25 mM, pH 7.8) at 0.8 A for 90 min. After transfer,
filters were blocked with PBS (pH 7.4) plus 2% bovine serum albumin
(BSA) and 0.1% Tween 20, termed PBS-BSA. Culture supernatants, pu-
rified monoclonal antibodies, or cattle sera were diluted in PBS-BSA and
exposed to the blot at room temperature for 2 h. After three washes in PBS
plus 0.1% Tween 20, blots were incubated for 1.5 h in peroxidase-conju-
gated goat anti-mouse IgG antibody (Pierce) or peroxidase-conjugated
goat anti-bovine IgG antibody (Vector Labs) diluted 1:20,000 in PBS-
BSA. The blots were again washed three times as described above and
developed for chemiluminescence using SuperSignal detection reagents
(Pierce).
ELISA procedure. Recombinant proteins were applied as a coating on
both PolySorp and MaxiSorp ELISA plates (Nunc Brand, Thermo Fisher
Scientific). Based on optimization experiments, the following conditions
were chosen. Plates were coated with 20 g/ml recombinant protein in
carbonate buffer and blocked in 0.2% casein and 0.1% Tween 20. Serum
samples were diluted 1:100 in 0.2% casein and 0.1% Tween 20. For detec-
tion, a mouse anti-bovine IgG-peroxidase conjugate was diluted 1:1,000
in 0.2% casein and 0.1% Tween 20 and the wash buffer was PBS with 0.1%
Tween 20. In other experiments, a sheep anti-bovine IgM-peroxidase
conjugate was used for detection. After incubation, the plate was washed
and tetramethylbenzidine (TMB) substrate was added. The substrate re-
action was stopped, and the absorbance was read. ELISAs using the
Parachek 2 test kit (Prionics AG, Switzerland) were performed according
to the manufacturer’s specifications.
Protein arrays. Protein arrays were constructed by spotting E. coli
expressed recombinant proteins on nitrocellulose and processed as de-
scribed previously (3). Available lipoproteins, membrane proteins, and
hypothetical proteins from M. avium subsp. paratuberculosis were tar-
geted for inclusion on the array, and the remaining proteins were ran-
domly selected from a collection of 600 recombinant proteins. Image
capture and densitometry analysis were performed using a Kodak
40000MM image station (Carestream Molecular Imaging). The Car-
estream software processed each spot at a predetermined size to yield
minimum, maximum, median, and mean gray values. Adjusted spot in-
tensities were calculated from the mean gray value and normalized to the
corresponding loading controls (array probed with anti-MBP) to account
for any slight variation that might be introduced in array production.
AlphaAssay to determine affinity and specificity of monoclonal an-
tibodies. Quantitative binding assays between truncated NlpC, its ho-
molog (MAP1204c), and 14C5 were conducted by employing a lumines-
cent microbead AlphaScreen technology (7, 13). The principle of this
assay relies upon a streptavidin donor bead, which recognizes a biotinyl-
ated ligand that binds a second target protein, which itself can be adsorbed
to acceptor beads that recognize mouse monoclonal IgG. Using this ap-
proach, an equilibrium competition binding assay was established in 96-
well-format one-half-area-opaque plates using the AlphaScreen anti-
mouse IgG kit purchased from PerkinElmer Life Sciences (Waltham, MA)
and carried out according to the following general procedures.
NlpC/14C5 competition assays were carried out in a final reaction
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volume of 25 l by adding each assay component to the following final
concentrations: 20 nM biotinylated NlpC-A, 1 nM 14C5, 20 g/ml anti-
mouse IgG AlphaScreen acceptor beads, and 20 g/ml AlphaScreen
streptavidin donor beads. A dilution series for each unlabeled competitor
protein was prepared. All reactions were performed in a buffer of PBS (pH
7.4) and 0.1% (vol/vol) Triton X-100. The reaction was performed over
the course of 2.5 h and was begun by mixing biotinylated NlpC-A, 14C5,
and various concentrations of unlabeled competitor. After 1 h of incuba-
tion time at room temperature, this solution was mixed with the acceptor
beads and allowed to incubate for an additional hour. Finally, donor beads
were added, and after 30 min of incubation time the AlphaScreen signal
(photon counts at 630 nm/s) was measured.
The AlphaScreen signal was normalized to wells containing no inhib-
itor, and a dose-response curve was generated by plotting normalized
signal versus log[competitor (M)]. Equilibrium dissociation constants
(KD) were calculated by nonlinear curve fitting to a four-parameter dose-
response inhibition curve (variable slope) using GraphPad Prism5 soft-
ware (GraphPad, La Jolla, CA) as previously described (13).
Statistical analysis. Analysis of reactivity intensities on the protein
array included the binomial test in which the null hypothesis P value was
set to 0.5. Under this null hypothesis, 48 proteins were predicted to show
stronger intensity in sera from JD cattle than in sera from healthy cattle
and 48 proteins would have a weaker signal in sera from JD cattle than in
sera from healthy cattle.
RESULTS
The NlpC protein is larger in non-paratuberculosis MAC
strains. Two stable hybridomas were obtained after immunizing
mice with the full-length NlpC recombinant protein. One hybrid-
oma cell line secreted monoclonal antibody (MAb) 14C5, and the
other secreted 8G6. The isotypes for 14C5 and 8G6 are IgG2a and
IgG1 heavy chains, respectively. Furthermore, both antibodies are
kappa light chain. Immunoblot analysis shows that these antibod-
ies react with both M. avium subsp. paratuberculosis strains and
non-paratuberculosis mycobacteria (Fig. 1). Unlike the recently
described MAb 17A12, which is 100% specific for M. avium subsp.
paratuberculosis (6), both 8G6 and 14C5 antibodies detected the
NlpC protein in MAC strains and Mycobacterium intracellulare.
In addition, both 8G6 and 14C5 detected a larger protein in
non-paratuberculosis mycobacteria than in M. avium subsp. para-
tuberculosis (Fig. 1 and 2D). This is contrary to the predicted an-
notation of each protein. In the M. avium subsp. paratuberculosis
K-10 genome, NlpC is annotated at 316 amino acids (gene iden-
tifier [ID], 2720835; calculated size, 33.4 kDa) whereas Mycobac-
terium avium subsp. hominissuis strain 104 NlpC is annotated as
only a 289-amino-acid protein (gene ID, 4527632; calculated size,
30.2 kDa). Alignment of additional mycobacterial NlpC proteins
further suggests that the strain K-10 protein may have been incor-
rectly annotated. Its 316 annotated residues start with the se-
quence VRSQ; however, comparison with other annotations of M.
avium complex strains has suggested that this protein may be only
279 residues long with translation beginning at the methionine of
the MKRIY. . . sequence (Fig. 2A). Therefore, in this study, the
MKRIY. . . sequence is considered the start of the protein in the
K-10 strain and its length is considered to be 279 residues. Table 1
shows the variable lengths of the primary sequence among mem-
bers of the Mycobacterium genus. Amino acid numbers range
from 249 in Mycobacterium tuberculosis to 311 in Mycobacterium
parascrofulaceum, with predicted sizes ranging from 26.08 to
32.46 kDa.
The N-terminal half of the protein is highly conserved with
only one amino acid difference at position 25 (Pro25Ala) observed
between M. avium subspecies strains (Fig. 2A). The C-terminal
half is more variable, with gaps in the sequence and 12 amino acid
differences among the four M. avium complex strains examined.
The C-terminal half also has a peptide repeat, which likely ac-
counts for the variability in amino acid numbers observed among
the different mycobacteria. Note that M. avium subsp. hominissuis
(M. avium 104) is the longest polypeptide among these strains.
SignalP 3.0 (www.cbs.dtu.dk/services/SignalP-3.0/) predicts an
N-terminal signal sequence with a probability of 1.000 and iden-
tified a very hydrophobic stretch from residues 3 to 26. The strong
potential for a signal sequence influenced the construction of var-
ious recombinant expression plasmids described here, such that
all three were constructed after the 25th codon (Fig. 2B). In addi-
tion, the full-length MAP1272c coding sequence, expressed as a
fusion with MBP, was constructed previously (5) and included in
these studies. The purity and apparent size of each recombinant
protein were evaluated with Coomassie blue-stained SDS-PAGE
gels (Fig. 2C).
Monoclonal antibodies 8G6 and 14C5 bind distinct epitopes
in NlpC. We also observed different reactivity patterns for each
monoclonal antibody (Fig. 1). 8G6 detected M. scrofulaceum (lane
3) and weakly recognized Mycobacterium kansasii (lane 14), but
the 14C5 antibody bound to neither. This suggested distinct
epitopes for each antibody, with 8G6 binding to a more conserved
epitope. Only Mycobacterium bovis, M. phlei, and Mycobacterium
abscessus whole-cell lysates did not react with either antibody. The
antibodies were mapped to a specific section of the protein using
the truncated peptides described in Fig. 2B and C. These data show
that 8G6 reacted with all three peptides whereas 14C5 reacted with
only the A(26 –279) and B(26 –168) truncations (Fig. 3). Therefore, the
14C5 epitope maps to a 49-amino-acid region from positions 26
to 74 on the N-terminal half of the protein whereas 8G6 bound an
epitope between amino acids 74 and 168 in the center (compare
FIG 1 The NlpC/P60 domain-containing protein varies in size among myco-
bacterial species. Two identical immunoblots were probed with 14C5 and 8G6
as indicated in the right margin. For all lanes, 0.6 g of the whole-cell lysate was
loaded. Lane 1, protein standards; lane 2, Mycobacterium avium subsp. silvati-
cum; lane 3, M. scrofulaceum; lane 4, M. abscessus; lane 5, M. avium subsp.
paratuberculosis K-10; lane 6, M. avium subsp. avium (ATCC 35713); lane 7,
M. bovis (ATCC 19210); lane 8, M. phlei; lane 9, M. bovis BCG; lane 10, M.
avium subsp. paratuberculosis (ATCC 19698); lane 11, M. avium subsp. avium
(ATCC 35716); lane 12, M. avium subsp. paratuberculosis (ATCC 43015); lane
13, M. intracellulare; lane 14, M. kansasii. Protein size standards are indicated
in kilodaltons in the left margin.
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Fig. 2B with Fig. 3). Both MAb epitopes appear to be linear, not
conformational, as judged by reactivity to denatured antigens fol-
lowing PAGE separation. Although the precise epitopes for each
MAb were not defined at a high resolution, these data confirm that
8G6 and 14C5 recognize distinct epitopes.
Characterization of MAb binding to NlpC. More detailed in-
sight into NlpC recognition by 14C5 and 8G6 was also achieved
through the use of a no-wash, solution-based binding assay (7). In
this approach, termed AlphaAssay, a biotinylated target protein
(in this case, NlpC-A) is incubated with a cognate MAb, and the
interaction between these two proteins brings a streptavidin-
coated luminescent donor bead into physical proximity to an anti-
IgG-derivatized luminescent acceptor bead. Biochemical con-
stants, in particular Kd (dissociation constant) values, can then be
FIG 2 Analysis of recombinant and native NlpC protein. (A) Amino acid sequence alignment of NlpC sequences from four M. avium complex strains.
Differences are highlighted in red, and gaps are shown. MAP K-10 is a bovine strain of M. avium subsp. paratuberculosis, MAP S397 is an ovine strain of M. avium
subsp. paratuberculosis, M. avium 104 is an M. avium subsp. hominissuis isolate, and ATCC 25291 is M. avium subsp. avium. (B and C) The full-length protein
and three truncated, overlapping polypeptides are shown schematically on a base pair scale (B) and by SDS-PAGE gel electrophoresis (C). The full-length protein
was expressed as a fusion with MBP while the three truncated peptides are polyhistidine tagged (lanes A, B, and C correspond to the A, B, and C peptides in panel
B). Lanes M contain protein size markers, and lane FL contains full-length NlpC (amino acids 1 to 279). (D) The native protein is detected by the monoclonal
antibody 14C5 from whole-cell extracts of M. avium complex strains. Note that M. avium subsp. avium (ATCC 35713) shows a larger protein than do M. avium
subsp. paratuberculosis strains. Lanes: 1, M. avium subsp. paratuberculosis K-10; 2, M. avium subsp. avium (ATCC 35713); 3, M. avium subsp. paratuberculosis
(ATCC 19698); 4, M. avium subsp. paratuberculosis (ATCC 43015).
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derived by competition of this interaction by including various
concentrations of unlabeled proteins in the assay. Interestingly,
while a strong signal was generated when biotinylated NlpC-A was
captured by 14C5 in this assay, no signal was detected when 8G6
was used as the capturing antibody (data not shown). Since both
of these MAbs recognize NlpC-A in the context of an immunoblot
(Fig. 3 above), this result strongly suggests that the 8G6 epitope is
not surface exposed in soluble NlpC-A.
Further information regarding the interactions between 14C5
and the two epitope-harboring NlpC truncations shown in Fig. 3
was derived from competition binding studies (Fig. 4 and Table
2). This revealed that NlpC-A and NlpC-B bound 14C5 with ex-
perimental Kd values of 15.2 and 10.7 nM, respectively. It is note-
worthy that the derived 95% confidence intervals for these values
overlap one another, which indicates that any differences in 14C5
binding to the NlpC truncations are statistically insignificant. Still,
the high affinity of 14C5 for a soluble form of its NlpC antigen
suggests that this MAb may be useful as a tool for detecting NlpC
in biological samples.
Observations using MAbs in diagnostic tests have demon-
strated the possibility that they may cross-react with proteins from
closely related species, but they may also react with closely related
proteins from the same organism. Indeed, NlpC has four ho-
mologs which appear to share the widely distributed NlpC/P60
catalytic domain that is characteristic of NlpC itself. These pro-
teins, encoded by MAP1203, MAP1204, MAP1928c, and
MAP0036, share sequence identities of 57, 55, 30, and 35%, re-
spectively, with NlpC encoded by MAP1272c across the region
defined by the NlpC/P60 domain (data not shown). Since this
level of sequence identity suggested that related NlpC/P60 pro-
teins have the potential to cross-react with 14C5, the ability of this
MAb to bind to purified, recombinant MAP1204 was examined
(Fig. 4 and Table 2). These results demonstrated that 14C5 had a
nearly 1,000-fold-greater affinity for both NlpC fragments ex-
pressed from MAP1272c than for that from MAP1204. Thus, this
significant affinity change indicates that 14C5 is highly specific for
NlpC, even compared to closely related M. avium subsp. paratu-
berculosis proteins.
Immunogenicity of the NlpC/P60 protein. The NlpC protein
was spotted on a protein array along with 95 other recombinant
proteins and analyzed with positive and negative JD serum sam-
ples from cattle. A complete listing of the proteins present on the
array along with their characteristics appears in Table S4 in the
supplemental material. Of these proteins, NlpC consistently
TABLE 1 Predicted sizes of NlpC/P60 domain-containing proteins among Mycobacterium sequences in the NCBI database
Mycobacterial species/strain(s) No. of amino acids Calculated size (kDa) Accession no. E valuea
M. avium subsp. paratuberculosis K-10 279 29.22 NP_960206.1 0.0
M avium subsp. avium ATCC 25291 279 29.21 ZP_05217173.1 0.0
M. avium subsp. hominissuis 104 289 30.24 YP_882390.1 3e174
M. avium subsp. paratuberculosis S397 264 27.61 EGO36914.1 3e159
M. intracellulare ATCC 13950 293 30.69 ZP_05225218.1 6e148
M. colombiense CECT 3035 258 27.32 ZP_08717501.1 1e122
M. kansasii ATCC 12478 277 28.92 ZP_04746612.1 1e121
M. ulcerans Agy99 259 27.41 YP_905539.1 7e117
M. marinum M 259 27.41 YP_001850685.1 7e117
M. parascrofulaceum ATCC BAA-614 311 32.46 ZP_06847019.1 8e108
M. bovis AF2122/97 230 23.96 NP_855245.1 2e103
M. tuberculosis H37Rv 230 23.96 NP_216082.1 2e103
M. tuberculosis CDC1551, F11, KZN 1435 249 26.08 NP_336070.1 2e103
a Database queried with the translated MAP1272c sequence from K-10.
FIG 3 8G6 and 14C5 MAbs bind distinct epitopes in NlpC. Shown are two
immunoblots exposed to the antibody indicated. 8G6 detects all three His-
tagged proteins whereas 14C5 detects only the proteins in lanes A and B. Lane
assignment designations are the same as those in Fig. 2C. The positions of the
kilodalton size standards are indicated in the left margins.
FIG 4 14C5 binds NlpC with low-nanomolar affinity and is highly selective
for NlpC versus a closely related protein. A no-wash, solution-based ELISA
method was used to determine dissociation constants (Kd) of 14C5 binding to
two forms of NlpC as well as that of the homologous protein, MAP1204.
Biotinylated MAP1272c-A was incubated with 14C5, and this interaction was
competed under equilibrium conditions with a dilution series of various un-
labeled proteins. Apparent Kd for each interaction pair were derived from 50%
inhibitory concentration values obtained from four-parameter dose-response
curves as shown. Whereas the Kd values for 14C5 binding to the MAP1272c A
and B fragments are largely identical (15.2 versus 10.7 nM, respectively), the
homologous protein, MAP1204, which is 55% identical to MAP1272c, is rec-
ognized nearly 1,000-fold more weakly (Table 2).
M. paratuberculosis NlpC Antigen
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ranked among the most antigenic to positive serum samples (Fig.
5). The positive serum samples (cows 28, 34, 70, and 192) are
readily distinguished from the negative serum sample (cow 2) by
reactivity with the whole-cell sonicate antigen (spot H12 in Fig. 5).
Densitometry analysis was performed on arrays to quantify reac-
tivity levels at each spot. Among the 14 positive JD samples, den-
sitometry analysis shows that NlpC had the strongest reactivity
among the recombinant proteins spotted on the array, but not
stronger than the whole-cell sonicate (Fig. 6). Cow 2, shown in Fig.
5, had the highest background reactivity among the three negative
serum samples but was still well below the positive-sample signals
(average intensity of positive samples was 61.2 compared to 9.8 for
negative samples in Fig. 6).
The NlpC recombinant protein was next tested along with 9
other proteins ranked among the most immunogenic, yet with
the least background reactivity as determined by a previous
protein array study (3). These included proteins encoded by
MAP0857c, MAP0865, MAP0900, MAP2077c, MAP2116c,
MAP3155c, MAP3735c, MAP3817c, and MAP4014. Each
served as the coating antigen in an ELISA similar to the
TABLE 2 14C5 antibody binding constants for selected M. avium subsp. paratuberculosis proteins
Competitor Kd
a R2 95% confidence interval (KD) No. of points analyzed No. of outliers S/N
b
Map1272cA 15.2 nM 0.957 10.7 to 21.6 nM 25 0 144
Map1272cB 10.7 nM 0.888 6.1 to 18.8 nM 24 0 92
Map1204 17.9 M 0.958 11.8 to 27.3 M 11 1 107
a Kd is the equilibrium dissociation constant. The smaller the dissociation constant, the tighter the antigen-antibody binding. Parameters for data analysis and curve fitting are
found in Materials and Methods.
b S/N denotes the ratio of experimental luminescence signal to noise. Background noise levels were obtained by measuring the signal of a mock assay where biotinylated Map1272cA
was omitted.
FIG 5 Assessment of the bovine humoral immune response to M. avium subsp. paratuberculosis recombinant proteins using 96-spot protein arrays. Shown are
6 protein arrays exposed to primary sera as indicated beneath each array. The arrows point to the spot containing the NlpC recombinant protein. The whole-cell
sonicate was spotted in H12 (lower right corner in each array). The anti-MBP monoclonal antibody reacts with all proteins on the array and serves as a control
to demonstrate the amount of protein spotted. Spot assignments along with densitometry data for each array are present in Tables S4 and S5 in the supplemental
material.
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Parachek ELISA against four positive and four negative JD se-
rum samples (Fig. 7). All of the proteins tested showed strong
reactivity to positive sample 4. Reactivity with this sample was
due to the presence of anti-MBP antibodies, as demonstrated
by preincubation of serum samples with different concentra-
tions of MBP (data not shown). However, NlpC still appeared
to be the most promising of the 10 proteins assayed. In order to
remove background reactivity associated with the MBP tag,
truncated polyhistidine-tagged proteins, with the 6His tag
proteolytically removed, were analyzed to determine which
section of NlpC is most immunogenic. The recombinant rep-
resenting amino acids 74 to 279 (MAP1272c-C) was the most
immunoreactive section of the protein (Fig. 8). As a conse-
quence, this fragment was used in subsequent ELISAs.
Comparison of MAP1272c with a commercial ELISA. Be-
cause NlpC was the strongest antigen among more than 100 re-
combinant proteins tested, it was of interest to determine if this
antigen might perform better than a commercial ELISA in identi-
fying cattle with Johne’s disease. When the MAP1272c-C frag-
ment was tested against different amounts of sera by ELISA, JD
positive serum samples (Pos 1 to 3 and 6 to 9) gave high signals
when 5 or 10 l of serum was used (Fig. 9A). Samples Pos 4 and
Pos 10 each showed signal increases with the concomitant increase
in serum volume added. However, JD positive samples 5, 11, and
12 gave signals at or below the background level observed with the
negative serum. Thus, when using 5 l of serum and 0.5 as the
cutoff, the MAP1272c-C fragment detected 9 of the 12 positive
samples (75%) and 1 of the 4 negative samples. However, the
Parachek 2 ELISA correctly identified all 12 positive samples and
did not react with any of the negative samples (data not shown).
This indicates that the commercial test was more sensitive than the
recombinant antigen alone.
We concluded the study by examining the reproducibility of
the MAP1272c ELISA using three independent MAP1272c-C pro-
tein preparations on two separate days. The reproducibility is very
good in terms of both batch-to-batch consistency and repeatabil-
ity on different days (Fig. 9B and C). The coefficient of variation
(CV) over all variables is less than 10%. For some negative sam-
ples, the variation is higher because values are below the linear
range. However, even those CVs are below 20%.
FIG 6 Quantitative densitometry of the most immunogenic arrayed proteins.
The density value is a measure of signal intensity for each protein on the array.
Reactivity levels were normalized to intensities obtained on the anti-MBP
array. Data are assembled from 14 positive sera and 3 negative sera. The aver-
age density for NlpC (MAP1272c) was above 60, whereas the average densities
for the remaining recombinant proteins were all below 40. Error bars indicate
the standard deviations of the means. Significance was determined using a
Student unpaired t test. *, P  0.05; **, P  0.01.
FIG 7 Serum reactivity against candidate antigens of M. avium subsp. paratuberculosis. Ten recombinant proteins were analyzed by ELISA with four positive and
four negative bovine serum samples.
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DISCUSSION
An antibody specific for M. avium subsp. paratuberculosis was
recently discovered by immunizing mice with a surface extract of
the bacterium (6). While the antigen that binds to this specific
antibody is present in other mycobacteria, it serendipitously binds
an epitope containing a single nucleotide polymorphism present
only in M. avium subsp. paratuberculosis. In the present study,
NlpC encoded by MAP1272c is also not specific to M. avium
subsp. paratuberculosis, as shown in the sequence alignment in
Fig. 2. However, it can be concluded that the 14C5 antibody is
specific for MAC strains, comprising M. intracellulare and three
subspecies of M. avium (16, 33). Furthermore, the antibody 8G6
also weakly bound NlpC in M. kansasii and M. scrofulaceum, two
species outside the MAC, and provides evidence that shared de-
terminants exist between these species and members of the MAC
group. The lack of antibody binding to M. bovis may be surprising
given the high similarity of NlpC/P60 domain-containing pro-
teins in Table 1; however, this has been observed with other MAbs
generated against M. avium subsp. paratuberculosis proteins (4)
and there are 54 amino acid differences between these species for
NlpC. Both of these antibodies demonstrated the variable size of
the NlpC protein as expressed from mycobacterial species. This
was also suggested based on calculated molecular weights of se-
lected mycobacterial species. The reason for this size difference
was not conclusively determined, but sequence analysis suggests
that the repeat region of the protein may account for this as ob-
served for other proteins (10).
While it appears that the MAbs described here are not mono-
specific to M. avium subsp. paratuberculosis, important features of
their reactivity to NlpC identified here may still have importance
in efforts toward a more accurate diagnosis of JD. First, while both
8G6 and 14C5 bind to NlpC, only 14C5 is capable of recognizing
native, soluble NlpC antigen. Second, the AlphaAssay results
demonstrate that 14C5 binds its NlpC target with a low-nanomo-
lar dissociation constant consistent with highly specific protein-
protein interactions (Table 2). In addition to this, 14C5 displays
high selectivity for NlpC relative to closely related protein anti-
gens, as judged by a roughly 1,000-fold increase in the equilibrium
dissociation constant for binding MAP1204 relative to NlpC (Ta-
ble 2). Separately, examination of the humoral reactivity of JD-
positive cattle toward full-length NlpC and its truncations dem-
onstrated that only NlpC-C peptide consistently retained
antigenicity comparable to that of the full-length counterpart for
most JD-positive cattle. Since this region of NlpC is not recog-
nized by 14C5, it is possible that the complementary desirable
features of strong seroreactivity of JD-positive cattle to the NlpC
C-terminal region, along with high-affinity binding between 14C5
and NlpC N-terminal regions, could be combined into a sand-
wich-type immunodiagnostic tool. While additional work is
clearly needed in this area, the results presented here constitute a
promising starting point for future research and development.
Surface-exposed proteins are best positioned to be major con-
tributors of host cell invasion, and antibodies against such pro-
teins have been shown to be effective at blocking invasion (26, 28).
NlpC contains invasion-associated domains in addition to the P60
domain mentioned in the introduction. Furthermore, signal pep-
tide predictions show a 29-amino-acid signal peptide and
PSORTb analysis predicts that NlpC is present in the cytoplasmic
membrane. Collectively, these results suggest that NlpC may be an
invasion protein. Further studies will be performed to determine
if either 8G6 or 14C5 antibodies block invasion of intestinal epi-
thelial cells.
Immunodiagnostic techniques may use different types of
antigens: whole inactivated cells, lipid, synthetic peptides, or
recombinant proteins. The difficulty is finding the best com-
promise between diagnostic sensitivity and specificity. Immu-
noblotting allows the simultaneous detection of antibodies
with different specificities and the potential detection of differ-
ent immunological profiles. We investigated the use of trun-
cated NlpC proteins as a potential antigen in the serodiagnosis
of JD. MAP1272c was initially shown to encode an antigenic
protein when a cell-free transcription-translation system for
protein expression was examined (22). The protein produced
in that study showed reactivity to positive pooled serum but
not to negative pooled serum. However, the in vitro expression
system yielded low quantities of protein and thus was good
only as an initial screening tool.
In order to extend those initial findings, the immunogenicity
of the NlpC recombinant protein was tested against over 100 other
M. avium subsp paratuberculosis recombinant proteins using con-
firmed positive and negative serum samples in this study. While
NlpC was the strongest antigen, it was shown that the MBP fusion
protein tag resulted in high background with some bovine serum
samples due to antibodies against MBP. Using the tag-free ver-
sions of the protein eliminated this issue, and it was used as the
coating antigen in subsequent ELISAs. ELISAs with this recombi-
nant protein were able to discriminate between most positive and
FIG 8 Immunoblot analysis of NlpC peptides with sera from cattle with JD.
The serum sample used is indicated beneath each blot. The anti-MBP mono-
clonal antibody identifies only the MBP fusion protein. Data show that the
section from amino acids 74 to 279 is the most immunogenic. Lanes: A,
MAP1272c A peptide (amino acids 26 to 279); B, MAP1272c B peptide (amino
acids 26 to 168); C, MAP1272c C peptide (amino acids 74 to 279); FL,
MAP1272c full-length peptide (amino acids 1 to 279). The positions of the
kilodalton size standards are indicated in the left margins.
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negative serum samples, but they did not detect three known pos-
itive samples that the Parachek 2 ELISA correctly identified. Thus,
even though antigen production was demonstrated to be highly
reproducible, it is not more sensitive than the Parachek 2 ELISA at
detecting positive serum samples. Furthermore, the NlpC protein
reacted strongly to negative serum sample 2 in a dose-dependent
manner (Fig. 9). This animal was confirmed negative for Johne’s
disease but may have been exposed to closely related environmen-
tal mycobacteria such as Mycobacterium avium subsp. avium. If
true, this result would highlight the potential for false-positive
reactions that can occur when antigens are not specific.
Another recently published study examined two recombinant
proteins, encoded by MAP1152 and MAP1156, in comparison to
the commercially available Idexx ELISA (2). Those proteins were
found to be discriminatory between positive and negative serum
samples, but the positive serum reacted more strongly in the Idexx
test. Collectively, both that study and the current study demon-
strate that recombinant proteins tested thus far do not improve
FIG 9 Performance of a MAP1272c-C ELISA. (A) The influence of three different serum amounts for each positive and negative sample is shown. (B and C) The
reproducibility among different preparations of the same antigen demonstrates lot-to-lot consistency for both positive (B) and negative (C) serum samples.
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upon commercially available ELISAs. However, there are many
more candidates remaining to be tested, and in all cases, they must
be measured against commercially available tests, which serve as
the standard that they must surpass (12).
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